Balfour Beatty PLC
10 July 2003
CONSORT HEALTHCARE REACHES FINANCIAL CLOSE FOR
£125 MILLION BLACKBURN HOSPITAL
Balfour Beatty, the international engineering, construction and services group,
announces today that Consort Healthcare (Balfour Beatty Capital Projects Ltd and
HSBC) has reached financial close for the PFI contract for the design,
construction, finance, maintenance and lifecycle replacement of a new, acute
hospital at Blackburn, Lancashire, by the East Lancashire Hospitals NHS Trust.
The concession period will be for 35 years following construction completion.
Construction is scheduled to be complete in 36 months.
Commenting on the contract, Mike Welton, Balfour Beatty Chief Executive, said
today: 'We are delighted to have reached financial close for Blackburn Hospital.
We look forward to bringing the same professionalism and discipline to the
task that ensured that both North Durham Hospital and the Edinburgh Royal
Infirmary opened on time and within budget just three years after their
financial close. We are dedicated to working with the Trust to create a
first-class healthcare facility to ensure that clinicians can do their best
work.'
Trust Chief Executive, John L Thomas, said: 'I am confident that by working in
partnership with Consort Healthcare we can deliver a state of the art single
site hospital which will help us provide the best possible care for our
patients.'
Acute services in Blackburn are currently provided at two sites. The project
involves extending one of them, the Queens Park Hospital, to integrate all acute
services as a single site. As a result, the scheme will provide all current
services at much greater efficiency levels and will also increase the number of
hospital beds and operating theatres.
The new extension will have 308 in-patient beds, which, with a further 68 beds
in refurbished existing accommodation, will combine with existing provision to
bring the total number of in-patient beds on site to 668. There is also an
expansion in day-case bed numbers, together with 11 in-patient and day-care
theatres, a cardiac catheter laboratory, an accident and emergency department to
cater for over 70,000 attendances and a new and expanded outpatient department.
Consort Healthcare is a 50/50 joint venture between Balfour Beatty Capital
Projects and HSBC. Construction will be carried out by a joint venture of
Balfour Beatty Construction Limited and Haden Young Limited, Balfour Beatty's
building services subsidiary. The facilities management contract will be
carried out by another Balfour Beatty subsidiary, Haden Building Management.
This is the fourth privately financed hospital for Balfour Beatty. Earlier in
2001 the £70 million North Durham Hospital opened to time and budget. The £220
million Edinburgh Royal Infirmary opened to time and budget earlier this year.
The £227 million University College London Hospital is under construction with a
planned opening date in summer 2008.
Enquiries to:
Tim Sharp
Tel: 020 7216 6800
www.balfourbeatty.com
Notes to Editors
1. In the healthcare sector, Balfour Beatty already has three
concessions, the Edinburgh Royal Infirmary and North Durham Hospital, through
Consort Healthcare, and the University College London Hospital. The total
construction value of these three projects is approaching £500 million. Balfour
Beatty's equity contribution to these three hospital projects is £24 million.
2. Full details of Balfour Beatty's involvement in PPP/PFI, in which it
has 16 concessions in all, are available on www.balfourbeattyppp.com.
This information is provided by RNS
The company news service from the London Stock Exchange E
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.